MIRM logo

Mirum Pharmaceuticals, Inc. (MIRM) EBIT

Annual EBIT:

-$87.61M+$21.55M(+19.74%)
December 31, 2024

Summary

  • As of today, MIRM annual earnings before interest & taxes is -$87.61 million, with the most recent change of +$21.55 million (+19.74%) on December 31, 2024.
  • During the last 3 years, MIRM annual EBIT has risen by +$85.81 million (+49.48%).
  • MIRM annual EBIT is now -2904.32% below its all-time high of -$2.92 million, reached on December 31, 2018.

Performance

MIRM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

Quarterly EBIT:

$2.60M+$7.59M(+152.17%)
September 30, 2025

Summary

  • As of today, MIRM quarterly earnings before interest & taxes is $2.60 million, with the most recent change of +$7.59 million (+152.17%) on September 30, 2025.
  • Over the past year, MIRM quarterly EBIT has increased by +$15.29 million (+120.52%).
  • MIRM quarterly EBIT is now at all-time high.

Performance

MIRM Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

TTM EBIT:

-$41.79M+$15.29M(+26.78%)
September 30, 2025

Summary

  • As of today, MIRM TTM earnings before interest & taxes is -$41.79 million, with the most recent change of +$15.29 million (+26.78%) on September 30, 2025.
  • Over the past year, MIRM TTM EBIT has increased by +$51.67 million (+55.28%).
  • MIRM TTM EBIT is now -64193.85% below its all-time high of -$65.00 thousand, reached on September 30, 2018.

Performance

MIRM TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

MIRM EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+19.7%+120.5%+55.3%
3Y3 Years+49.5%+107.9%+70.7%
5Y5 Years-60.0%+112.0%+51.4%

MIRM EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+49.5%at high+107.6%at high+70.7%
5Y5-Year-60.0%+49.5%at high+105.5%at high+75.9%
All-TimeAll-Time-2904.3%+49.5%at high+105.5%>-9999.0%+75.9%

MIRM EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
$2.60M(+152.2%)
-$41.79M(+26.8%)
Jun 2025
-
-$4.99M(+67.1%)
-$57.08M(+25.2%)
Mar 2025
-
-$15.18M(+37.3%)
-$76.32M(+12.9%)
Dec 2024
-$87.61M(+19.7%)
-$24.22M(-91.0%)
-$87.61M(+6.3%)
Sep 2024
-
-$12.68M(+47.7%)
-$93.46M(+11.8%)
Jun 2024
-
-$24.23M(+8.4%)
-$105.92M(+0.0%)
Mar 2024
-
-$26.47M(+12.0%)
-$105.96M(+0.6%)
Dec 2023
-$109.15M(+16.8%)
-$30.07M(-19.6%)
-$106.64M(+3.7%)
Sep 2023
-
-$25.15M(-3.6%)
-$110.73M(+6.5%)
Jun 2023
-
-$24.27M(+10.6%)
-$118.46M(+5.7%)
Mar 2023
-
-$27.15M(+20.5%)
-$125.63M(+4.3%)
Dec 2022
-$131.22M
-$34.16M(-3.9%)
-$131.22M(+8.0%)
Sep 2022
-
-$32.88M(-4.6%)
-$142.63M(+6.5%)
Jun 2022
-
-$31.44M(+4.0%)
-$152.58M(+3.8%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$32.74M(+28.2%)
-$158.54M(+8.6%)
Dec 2021
-$173.41M(-66.3%)
-$45.58M(-6.4%)
-$173.41M(-5.2%)
Sep 2021
-
-$42.82M(-14.5%)
-$164.79M(-14.7%)
Jun 2021
-
-$37.40M(+21.4%)
-$143.68M(-10.6%)
Mar 2021
-
-$47.61M(-28.9%)
-$129.88M(-24.5%)
Dec 2020
-$104.30M(-90.5%)
-$36.95M(-70.2%)
-$104.30M(-21.3%)
Sep 2020
-
-$21.72M(+8.0%)
-$86.00M(-7.3%)
Jun 2020
-
-$23.60M(-7.1%)
-$80.15M(-13.5%)
Mar 2020
-
-$22.03M(-18.1%)
-$70.59M(-28.9%)
Dec 2019
-$54.74M(-1777.3%)
-$18.66M(-17.6%)
-$54.74M(-51.7%)
Sep 2019
-
-$15.87M(-13.1%)
-$36.09M(-77.9%)
Jun 2019
-
-$14.03M(-126.9%)
-$20.28M(-224.6%)
Mar 2019
-
-$6.18M(-9413.8%)
-$6.25M(-9513.8%)
Dec 2018
-$2.92M
-
-
Sep 2018
-
-$65.00K
-$65.00K

FAQ

  • What is Mirum Pharmaceuticals, Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. annual EBIT year-on-year change?
  • What is Mirum Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
  • What is Mirum Pharmaceuticals, Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. TTM EBIT year-on-year change?

What is Mirum Pharmaceuticals, Inc. annual earnings before interest & taxes?

The current annual EBIT of MIRM is -$87.61M

What is the all-time high annual EBIT for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$2.92M

What is Mirum Pharmaceuticals, Inc. annual EBIT year-on-year change?

Over the past year, MIRM annual earnings before interest & taxes has changed by +$21.55M (+19.74%)

What is Mirum Pharmaceuticals, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of MIRM is $2.60M

What is the all-time high quarterly EBIT for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $2.60M

What is Mirum Pharmaceuticals, Inc. quarterly EBIT year-on-year change?

Over the past year, MIRM quarterly earnings before interest & taxes has changed by +$15.29M (+120.52%)

What is Mirum Pharmaceuticals, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of MIRM is -$41.79M

What is the all-time high TTM EBIT for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$65.00K

What is Mirum Pharmaceuticals, Inc. TTM EBIT year-on-year change?

Over the past year, MIRM TTM earnings before interest & taxes has changed by +$51.67M (+55.28%)
On this page